Loading briefing details...
News Brief
By: PointLine Media Research & Editorial Team
September 22, 2026
This lawsuit highlights the critical need for transparency in the rapidly expanding supplement industry. By challenging the validity of health claims and sourcing ethics, the case serves as a warning to brands that rely on vague marketing, potentially forcing stricter regulatory scrutiny and consumer protection standards moving forward.
Animal Partisan has initiated legal action against Rahal Biosciences, the producer of the popular bovine colostrum supplement ARMRA, alleging significant misrepresentations regarding product efficacy and animal welfare standards. Filed in the Superior Court of the District of Columbia, the complaint challenges the brand's broad health claims, which suggest benefits for immunity, metabolism, and gut health. The lawsuit argues that these assertions lack support from peer-reviewed human clinical trials, relying instead on insufficient data and consumer surveys.
The litigation further scrutinizes ARMRA’s marketing regarding its supply chain and ethical sourcing. While the company claims to utilize surplus colostrum from cows on family-owned farms that prioritize animal welfare, the complaint alleges these claims are unsubstantiated. Animal Partisan contends that the brand fails to disclose farm conditions, utilizes misleading imagery, and ignores research suggesting that true surplus colostrum is rarely available in standard dairy operations.
Represented by Richman Law & Policy, Animal Partisan aims to curb what it describes as deceptive advertising practices within the booming $1.1 billion colostrum industry. By challenging these marketing tactics, the organization seeks to protect consumers from unsubstantiated health promises while advocating for greater transparency and accountability regarding the treatment of animals used in the production of dietary supplements.